Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekFierceBiotech ↗
After Jenny Pearson's daughter Elise first had a seizure at 16 months old, an MRI came back clean-her brain "l…
The WeekBriefing
Ultragenyx’s post-approval momentum was checked by a phase 3 Angelman failure. The immediate read is less abou…
The WeekBioPharma Dive ↗
Pelacarsen didn't protect heart health despite lowering levels of a protein particle, "Lp(a)," in a large clin…
The WeekFiercePharma ↗
After Jenny Pearson's daughter Elise first had a seizure at 16 months old, an MRI came back clean-her brain "l…
The WeekFierceBiotech ↗
Novartis' Ionis-partnered drug designed to lower levels of Lp(a), a known cardiovascular risk factor, failed t…
The WeekBriefing
BioPharma Dive’s weekly chart roundup pointed to resilient China partnering, sharp pressure on two mid-cap bio…
The WeekSTAT News ↗
"A click, signature, or brief review should not magically transfer responsibility from an AI developer or plat…
The WeekSTAT News ↗
A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a majo…
The WeekBioPharma Dive ↗
The drugmaker is leaning on a better side effect profile compared to drugs from J&J, Pfizer and Regeneron …
The WeekPharmaVoice ↗
The FDA recently OK'd Gilead's novel HIV combo med, and cell therapy deals have fallen dramatically in two yea…
The WeekPharmaVoice ↗
More than 25 years after it was declared eliminated, measles has surged back. But drug R&D is still in ear…
The WeekBioPharma Dive ↗
Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist pos…
The WeekFiercePharma ↗
Following a string of customer complaints, a Form 483 and a recall this past spring, a Fresenius manufacturing…
The WeekFierceBiotech ↗
Amid the rise of psychedelics in the mental health space, researchers have begun to explore psilocybin as a tr…
The WeekBriefing
Medicare has launched a “bridge” model tied to the Trump administration’s MFN pricing deal with Eli Lilly and …
The WeekPharmaceutical Technology ↗
The FDA is looking to modernise its regulatory framework for drugs derived from plants, algae, and fungi.…
The WeekPharmaceutical Technology ↗
Ionis claims Zanvastro will become available to US patients with rare neurodegenerative condition, Alexander d…
The WeekSTAT News ↗
"Is CDC now applying different standards to state data depending on who governs the state or what political pa…
The WeekBioPharma Dive ↗
Superluminal Medicines banked $60 million in funding to support development of a drug designed to work similar…
The WeekBioPharma Dive ↗
With its latest foray into China, GSK acquired rights from Hutchmed to an "antibody-targeted therapy conjugate…
The WeekPharmaVoice ↗
Wall Street analysts believe that a more cautious approach to manufacturing, study enrollment and side effect …
The WeekPharmaVoice ↗
Two House Republicans are asking the FDA to increase oversight of China-generated clinical data after three tr…
The WeekFiercePharma ↗
RNA-based vaccines and therapeutics may have faced a bumpy road in the U.S. recently, but a major new federal …
The WeekFierceBiotech ↗
Fortrea has agreed to acquire the early-phase services division of fellow CRO Worldwide Clinical Trials for $4…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.